Breaking News Instant updates and real-time market news.

HON

Honeywell

$106.94

-8.67 (-7.50%)

, GPS

Gap

$26.25

3.47 (15.23%)

16:17
10/07/16
10/07
16:17
10/07/16
16:17

On The Fly: Top stock stories for Friday

Stocks began the session in positive territory thanks in part to a relatively tame jobs report. The market was unable to hold its opening gains and eventually crossed into negative territory, where the averages spent most of the morning and early afternoon. As the afternoon wore on, the averages reversed and came back to closed to unchanged. With the news flow slowing, the market limped into the close. Trading on Monday may be slow again, as U.S. bond markets will be closed and a number of Asian markets, including Japan and Hong Kong, will be shut for holidays. ECONOMIC NEWS: In the U.S., nonfarm payrolls increased 156,000 in September following August's upwardly revised 167,000 gain, but was still weaker than the 172,000 median forecast of economists. The unemployment rate rose to 5% from 4.9% previously. The wholesale report slightly underperformed with 0.2% August inventory drop. Consumer credit rose more than expected in August to $25.9B. Baker Hughes reported the U.S. rig count was up 2 rigs from last week to 524, with oil rigs up 3, gas rigs down 2, and miscellaneous rigs up 1. In Europe, German industrial production rose 2.5% in August, while U.K. industrial production fell by 0.4% due to a drop in oil and gas production. Additionally, the British pound plunged more than 6% in early morning trading, sending the currency to a new 31-year low. The "flash crash" has traders baffled, as some have pointed to a potential trader error and others have blamed the price action on Brexit fears and remarks from French President Francois Hollande calling for tough Brexit talks. COMPANY NEWS: Shares of Honeywell (HON) dropped 7.5% after the company reported preliminary third-quarter profit below its prior forecast and cut the top end of the 2016 earnings target as sales slump for aircraft parts... Meanwhile, shares of Gap (GPS) advanced 15.23% after the retailer said same-store sales increased 4% at its Old Navy brand in September, despite its namesake brand again posting lower comparable sales. MAJOR MOVERS: Among the notable gainers was Sunrun (RUN), which advanced 6.05% after Goldman analyst Brian Lee upgraded the stock to Buy from Neutral, citing "above-market growth potential." Also higher were Frontier Communications (FTR) and Centurylink (CTL), which gained 6% and 2.93%, respectively, after FCC Chairman Tom Wheeler unveiled a plan that would allow many small businesses to pay lower prices for high-capacity data and voice connections known as special access lines under a scaled-back proposal to reform the $45B per year market, according to Reuters. Wheeler may seek a final vote soon, the publication added. Among the noteworthy losers was Clovis Oncology (CLVS), which fell 17.78% after the company announced the presentation of the primary efficacy and safety data from its NDA dataset for rucaparib, which is currently under priority review with FDA for the monotherapy treatment of advanced ovarian cancer in select patients. Adam Feuerstein, biotech reporter for TheStreet.com, commented that the weakness in Clovis shares was likely due to comparisons being made between its data and AstraZeneca's (AZN) Lynparza, another drug in the same space that is already approved to treat certain ovarian cancer patients. Also lower was PPG Industries (PPG), which slid 8.28% after the company cut its 2016 fiscal third quarter guidance. Additionally, Tyson Foods (TSN) dropped 8.91% after Pivotal Research downgraded the stock two notches to Sell from Buy, saying that a new class action lawsuit will lead to "intense scrutiny" of chicken producers, will cause investors to question the sustainability of chicken margins, and will probably cause Tyson's multiple to decline. In response, Tyson said it disputed the allegations in the complaints, as well as the "speculative conclusions reached by the analyst," and will defend itself in court. INDEXES: The Dow fell 28.01, or 0.15%, to 18,240.49, the Nasdaq lost 14.45, or 0.27%, to 5,292.40, and the S&P 500 declined 7.03, or 0.33%, to 2,153.74.

HON

Honeywell

$106.94

-8.67 (-7.50%)

GPS

Gap

$26.25

3.47 (15.23%)

TSN

Tyson Foods

$67.75

-6.63 (-8.91%)

RUN

Sunrun

$6.49

0.37 (6.05%)

FTR

Frontier Communications

$4.23

0.24 (6.02%)

CTL

CenturyLink

$27.76

0.79 (2.93%)

CLVS

Clovis

$29.41

-6.36 (-17.78%)

AZN

AstraZeneca

$32.29

0.03 (0.09%)

PPG

PPG Industries

$93.72

-8.47 (-8.29%)

  • 07

    Oct

  • 12

    Oct

  • 20

    Oct

  • 21

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 16

    Nov

  • 23

    Feb

HON Honeywell
$106.94

-8.67 (-7.50%)

10/07/16
JPMS
10/07/16
NO CHANGE
JPMS
Overweight
Honeywell selloff on guidance a buying opportunity, says JPMorgan
JPMorgan analyst C. Stephen Tusa recommends using the selloff in shares of Honeywell following the company's Q3 guidance cut as a buying opportunity. The analyst puts himself in the "not that bad in the grand scheme" camp and notes Honeywell has $25B in balance sheet capacity. Tusa has an Overweight rating on the shares.
10/07/16
BERN
10/07/16
NO CHANGE
BERN
Honeywell still has positive attributes, says Bernstein
After Honeywell lowered its guidance and announced restructuring plans, Bernstein analyst Steven Winoker said that macro conditions and margins/restructuring led to the disappointing news. However, the analyst says that there are still multiple reasons to be upbeat on the stock, including his belief that the company's EPS growth will exceed 8% next year, and what he sees as the company's high margins and large cash reserves. The analyst keeps a $135 price target and Outperform rating on the stock.
10/06/16
BARD
10/06/16
INITIATION
Target $135
BARD
Honeywell initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Honeywell with an Outperform and a $135 price target.
10/06/16
BARD
10/06/16
INITIATION
Target $135
BARD
Outperform
Honeywell initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Honeywell with an Outperform and a $135 price target.
GPS Gap
$26.25

3.47 (15.23%)

10/07/16
DBAB
10/07/16
UPGRADE
Target $24
DBAB
Hold
Gap upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Paul Trussell upgraded Gap to Hold saying the company's near- to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. Trussell raised his price target for the shares to $24 from $18.
10/07/16
UBSW
10/07/16
NO CHANGE
Target $16
UBSW
Sell
Gap distribution center fire impact not done being felt, says UBS
UBS analyst Michael Binetti noted Gap's distribution center fire in August had a significant impact on September sales and that the company estimates that the fire will be a 3 point drag to October same-store sales as well. Additionally, Binetti said Florida, Georgia and South Carolina account for 10% of the company's North America store count and that Gap will close some stores amid this weekend's hurricane, further impacting October sales. The company mentioned that merchant margins were higher than expected which should offset any negative earnings impact, however. The analyst is cautious of the company's ability to pull back on promotions to drive a comp inflection and reiterated his Sell rating and $16 price target on Gap shares.
10/07/16
JEFF
10/07/16
NO CHANGE
Target $32
JEFF
Buy
Jefferies sees 'sizable upside potential' in Gap shares
Jefferies analyst Randal Konik raises his price target for Gap shares to $32 from $30 following the retailer's September results. Trends are Old Navy are accelerating while a bottom setting in at The Gap, Konik tells investors in a research note. The analyst sees an "asymmetric risk/reward" for shares with downside "fairly limited" and "sizable upside potential." He sees easy comparisons as a near-term catalyst and keeps a Buy rating on the shares.
10/07/16
10/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying the company's near-to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. 2. DuPont Fabros (DFT) upgraded to Buy from Hold at Stifel with analyst Matthew Heinz saying the company's current valuation reflects an expectation for weaker Q3 leasing activity. 3. Ralph Lauren (RL) upgraded to Conviction Buy from Buy at Goldman with analyst Lindsay Drucker Mann saying CEO Stefan Larsson's turnaround is firmly in place. 4. Restoration Hardware (RH) upgraded to Neutral from Underperform at Buckingham with the firm's analyst believing $1.60-$1.80 fiscal 2016 earnings are achievable, reducing the risk of further downward earnings revisions. 5. Vivint Solar (VSLR) upgraded to Neutral from Sell at Goldman with analyst Brian Lee saying the company is "moving on the path toward recovery." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TSN Tyson Foods
$67.75

-6.63 (-8.91%)

10/07/16
PIVT
10/07/16
DOWNGRADE
PIVT
Sell
Tyson Foods downgraded to Sell from Hold at Pivotal Research
Pivotal analyst Timothy Ramey downgraded Tyson Foods to Sell and slashed his price target to $40 from $100 due to the broiler price-fixing alleged in the class action complaint filed on September 2. Ramey said the complain alleges supply collusion occurred through nonpublic data exchange; detailed industry reports compiled on a daily or weekly basis by Agri Stats. Supposedly, the data has telling clues as to the identity of the other industry participants, making it is easy for the industry to collude on production cuts since they provide non-public information to Agri Stats on future production intentions. The analyst wondered why margins improved dramatically over the past seven years in a historically undisciplined industry. Ramey believes the class-action suit has merit and will lead to intense scrutiny of the broiler industry and questions the sustainability of chicken margins. He expects Tyson shares will be pressured until this complex issue is resolved and damages could be very substantial.
10/07/16
10/07/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tyson Foods (TSN) downgraded to Sell from Hold at Pivotal Research with analyst Timothy Ramey citing the broiler price-fixing alleged in the class action complaint filed on September 2. 2. SolarEdge (SEDG) was downgraded to Sell from Neutral at Goldman while the firm also downgraded First Solar (FSLR) to Neutral from Buy. 3. CIT Group (CIT) downgraded to Hold from Buy at Stifel with analyst Christopher Brendler saying investors should sell into the rally that will result from the "impressive" price that the company received for its aircraft business and the approval of its capital plan by the Fed. 4. Fifth Third (FITB) downgraded to Hold from Buy at Jefferies with analyst Ken Usdin saying the shares are reasonably valued following the recent rally. 5. Blackhawk (HAWK) downgraded to Neutral from Buy at BofA/Merrill with analyst David Chu saying the firm's channel checks indicate that conversions to EMV, the new standard for chip-based debit/credit card transactions, are taking longer than expected, which he believes could impact Blackhawk's 2016 guidance and expectations for 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
JEFF
10/07/16
NO CHANGE
JEFF
Tyson Foods price fixing allegations 'unfounded,' says Jefferies
10/07/16
JEFF
10/07/16
NO CHANGE
JEFF
Follow-up: Tyson Foods price fixing allegations 'unfounded,' says Jefferies
Jefferies analyst Akshay Jagdale believes weakness in Tyson shares due to price fixing allegations is overdone. The analyst sees no evidence of consumers being harmed by price fixing and believes chicken prices and the industry is highly competitive and consumers have benefited from this. His analysis of the industry indicates historical chicken price movements can be explained by fundamentals and price discovery is relatively transparent.
RUN Sunrun
$6.49

0.37 (6.05%)

10/06/16
GSCO
10/06/16
UPGRADE
GSCO
Buy
Sunrun upgraded to Buy from Neutral at Goldman
Goldman analyst Brian Lee upgraded Sunrun to Buy from Neutral with a $10 price target, citing "above-market growth potential."
10/06/16
GSCO
10/06/16
UPGRADE
GSCO
Buy
Sunrun upgraded to Buy from Neutral at Goldman
09/08/16
09/08/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform, $160 target at Cowen with analyst Jeffrey Osborne saying the company is well positioned for the long term but has a "material amount of execution risk" over the next 12 to 18 months. 2. AutoNation (AN) initiated with a Buy at CL King. 3. Wingstop (WING) initiated with an Overweight at KeyBanc. 4. Vivint Solar (VSLR), Sunrun (RUN), and SolarEdge (SEDG) initiated with an Outperform at JMP Securities with the firm initiated First Solar (FSLR) and SunPower (SPWR) with an Underperform. The firm also initiated Canadian Solar (CSIQ) with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/16
JMPS
09/08/16
INITIATION
Target $8.5
JMPS
Outperform
Sunrun initiated with an Outperform at JMP Securities
JMP Securities analyst Joseph Osha initiated Sunrun with an Outperform and $8.50 price target.
FTR Frontier Communications
$4.23

0.24 (6.02%)

09/06/16
MACQ
09/06/16
UPGRADE
MACQ
Neutral
Frontier Communications upgraded to Neutral from Underperform at Macquarie
Macquarie analyst Amy Young upgraded Frontier Communications to Neutral with a $4.75 price target citing healthy dividend coverage.
09/19/16
WELS
09/19/16
NO CHANGE
WELS
Concerns about Frontier Communications leverage overdone, says Wells Fargo
Wells Fargo says that some investors have expressed concern about Frontier's leverage ratio. Specifically, the firm says there are some worries that if Frontier has difficulty integrating the Verizon (VZ) assets it purchased, it may trigger bank covenants. However, Wells says that Frontier's synergy realization and subscription outlook have improved since Q2. Wells adds that the company's dividend is "very secure neat-term," and it keeps an Outperform rating on the shares.
07/18/16
MSCO
07/18/16
DOWNGRADE
Target $5.4
MSCO
Equal Weight
Frontier Communications downgraded to Equal Weight at Morgan Stanley
Morgan Stanley analyst Simon Flannery downgraded Frontier Communications to Equal Weight from Overweight and lowered its price target to $5.40 from $6 citing upside risk to capex, increasing regulatory risks, and execution overhangs.
07/11/16
MACQ
07/11/16
INITIATION
Target $4.65
MACQ
Underperform
Frontier Communications initiated with an Underperform at Macquarie
Macquarie analyst Amy Yong initiated Frontier Communications with an Underperform and $4.65 price target. The analyst said Frontier is the most susceptible to cable competition, convergence of wireline/wireless, and the potential threat of wireless substitution particularly if 5G speeds are achieved, combined with FiOS integration risk, drives her Underperform rating.
CTL CenturyLink
$27.76

0.79 (2.93%)

07/11/16
MACQ
07/11/16
INITIATION
Target $31
MACQ
Neutral
CenturyLink initiated with a Neutral at Macquarie
Macquarie analyst Amy Yong initiated CenturyLink with a Neutral and $31 price target citing valuation, data center monetization that could be capped, and challenging residential growth.
06/21/16
EVER
06/21/16
INITIATION
Target $28
EVER
Hold
CenturyLink initiated with a Hold at Evercore ISI
Evercore ISI analyst Robert Gutman initiated CenturyLink with Hold and a $28 price target.
05/03/16
WELS
05/03/16
DOWNGRADE
WELS
Market Perform
CenturyLink downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche downgraded CenturyLink to Market Perform citing a lack of near-term catalysts to move shares higher as well as longer term structural concerns. The company's higher margin legacy revenues are declining faster than growth in lower margin strategic services revenue, Fritzsche tells investors in a research note. He lowered his price target range for the shares to $30-$33 from $43-$45.
07/18/16
MSCO
07/18/16
DOWNGRADE
Target $27
MSCO
Underweight
CenturyLink downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Simon Flannery downgraded CenturyLink to Underweight and lowered its price target to $27 from $31 citing upside risk to capex, increasing regulatory risks, and execution overhangs.
CLVS Clovis
$29.41

-6.36 (-17.78%)

10/07/16
RHCO
10/07/16
NO CHANGE
Target $50
RHCO
Buy
Clovis selloff a buying opportunity, says SunTrust
SunTrust analyst Peter Lawson views today's selloff in shares of Clovis Oncology as a buying opportunity, saying today's concern "seems like noise." The analyst has a Buy rating on the stock with a $50 price target. Clovis is down 13%, or $4.64, to $31.13 but is well off the day's lows.
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).
10/04/16
PIPR
10/04/16
NO CHANGE
Target $42
PIPR
Neutral
Clovis price target raised to $42 from $14 at Piper Jaffray
Piper Jaffray analyst Steven Breazzano raised his price target for Clovis Oncology (CLVS) to $42 after taking a "comprehensive look" at the PARP inhibitor landscape in ovarian cancer and beyond. The company's PARP inhibitor rucaparib has demonstrated an active profile in ovarian cancer and all signs point to an approval in the 3L+ setting early next year, Breazzano tells investors in a research note. The analyst, however, believes the ultimate key is success in the earlier maintenance setting, and he thinks the race may still be Tesaro's (TSRO) niraparib's to lose. Breazzano keeps a Neutral rating on Clovis.
10/07/16
PIPR
10/07/16
NO CHANGE
PIPR
Neutral
Piper still sees Clovis' rucaparib getting broader indication than Lynparza
Piper Jaffray analyst Steven Breazzano said the rucaparib response rates in platinum resistant and platinum refractory patients of 25% and 0%, respectively, reported by Clovis Oncology (CLVS) are lower than some may have been expecting and "seemingly negative on the surface." However, he continues to believe rucaparib will be approved in BRCA patients who have received 2+ lines of therapy, which is an earlier and broader patient population than assigned to competitor AstraZeneca's (AZN) Lynparza, he tells investors. The ultimate market potential and key to success is the maintenance setting, for which TESARO's (TSRO) niraparib is still best-positioned, adds Breazzano, who keeps a Neutral rating on Clovis shares.
AZN AstraZeneca
$32.29

0.03 (0.09%)

09/23/16
PIPR
09/23/16
INITIATION
PIPR
Overweight
AstraZeneca initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started AstraZeneca with an Overweight rating and GBP 60 price target.
09/13/16
EXAN
09/13/16
DOWNGRADE
EXAN
Neutral
AstraZeneca downgraded to Neutral from Outperform at Exane BNP Paribas
09/23/16
09/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Brian Nowak initiated Activision Blizzard (ATVI) and Electronic Arts (EA), both with Overweight ratings. The analyst is bullish on the digital gaming shift away from "units sold" to a business model based on users, engagement, and digital monetization. He sees digital in-game offerings resulting in recurring and growth user bases, increased per-game engagement, and further monetization opportunities. 2. AstraZeneca (AZN) and GlaxoSmithKline (GSK) both initiated with Overweight ratings by Piper Jaffray analyst Richard Purkiss. 3. Achillion (ACHN) initiated with an Outperform by Wedbush analyst Heather Behanna, who set a $13 price target on the shares. 4. Sysco (SYY) initiated with an Underweight at Barclays and $48 price target by analyst Karen Short. 5. Five Below (FIVE), Dollar Tree (DLTR) and Dollar General (DG) all initiated with Equal Weight ratings by Barclays analyst Karen Short. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PPG PPG Industries
$93.72

-8.47 (-8.29%)

10/07/16
WELS
10/07/16
NO CHANGE
WELS
PPG Industries removed from Priority List at Wells Fargo
07/26/16
GHSC
07/26/16
UPGRADE
Target $130
GHSC
Buy
PPG Industries upgraded to Buy from Accumulate at Seaport Global
Seaport Global analyst Michael Harrison upgraded PPG to Buy from Accumulate and raised its price target to $130 from $125. The analyst increased the outlook for the coatings business and adjusted the model to reflect the divestiture of most the Glass segment and said PPG is a high-quality core holding that should be able to leverage organic and inorganic growth opportunities, maintain focus on cost discipline, and return cash to shareholders.
06/23/16
LBOW
06/23/16
UPGRADE
LBOW
Buy
PPG Industries upgraded to Buy from Neutral at Longbow
Longbow analyst Dmitry Silverstein upgraded PPG Industries to Buy with a $130 price target on shares. The analyst believes PPG's efforts to improve organic growth may be gaining momentum given evidence of accelerating growth in PPG's store channel and increased traction from new higher priced products at Menards. Further, faster growth of auto-OEM, Industrial, Aerospace and EMEA businesses in 2H16, driving above-consensus performance, upward earnings revisions and expanding multiples, the analyst wrote.
05/06/16
LYON
05/06/16
DOWNGRADE
LYON
Outperform
PPG Industries downgraded to Outperform from Buy at CLSA

TODAY'S FREE FLY STORIES

CLI

Mack-Cali Realty

$29.17

0.64 (2.24%)

06:37
12/09/16
12/09
06:37
12/09/16
06:37
Downgrade
Mack-Cali Realty rating change  »

Mack-Cali Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXP

Boston Properties

$129.50

0.66 (0.51%)

06:36
12/09/16
12/09
06:36
12/09/16
06:36
Downgrade
Boston Properties rating change  »

Boston Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNR

Vanguard Natural

$1.12

0.1083 (10.72%)

06:35
12/09/16
12/09
06:35
12/09/16
06:35
Downgrade
Vanguard Natural rating change  »

Vanguard Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDSN

Hudson Technologies

$7.33

0.01 (0.14%)

06:35
12/09/16
12/09
06:35
12/09/16
06:35
Syndicate
Hudson Technologies 6.429M share Secondary priced at $7.00 »

William Blair and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 09

    Dec

NVCR

Novocure

$8.75

0.4 (4.79%)

06:34
12/09/16
12/09
06:34
12/09/16
06:34
Conference/Events
Novocure to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

LFUS

Littelfuse

$154.58

3.1 (2.05%)

06:33
12/09/16
12/09
06:33
12/09/16
06:33
Earnings
Littelfuse backs Q4 adjusted EPS view $1.45-$1.59, consensus $1.52 »

Backs Q4 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FLR

Fluor

$56.00

1.33 (2.43%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIMO

Gigamon

$47.95

-0.4 (-0.83%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Upgrade
Gigamon rating change  »

Gigamon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNC

Wabash

$15.13

0.44 (3.00%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Initiation
Wabash initiated  »

Wabash initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$141.89

-3.09 (-2.13%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Initiation
Parker-Hannifin initiated  »

Parker-Hannifin initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$72.20

0.19 (0.26%)

, VLKAY

Volkswagen

$28.75

-0.188 (-0.65%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Periodicals
Daimler CEO says company will be 2016's biggest luxury carmaker, Reuters says »

Daimler CEO Dieter…

DDAIF

Daimler AG

$72.20

0.19 (0.26%)

VLKAY

Volkswagen

$28.75

-0.188 (-0.65%)

BMWYY

BMW

$31.39

0.205 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

GWR

Genesee & Wyoming

$79.54

1.77 (2.28%)

06:31
12/09/16
12/09
06:31
12/09/16
06:31
Hot Stocks
Genesee & Wyoming reports November traffic up 3.7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

06:30
12/09/16
12/09
06:30
12/09/16
06:30
Downgrade
DAVIDsTEA rating change  »

DAVIDsTEA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCN

Waste Connections

$76.63

0.04 (0.05%)

06:29
12/09/16
12/09
06:29
12/09/16
06:29
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPR

Spirit AeroSystems

$61.26

0.65 (1.07%)

06:28
12/09/16
12/09
06:28
12/09/16
06:28
Downgrade
Spirit AeroSystems rating change  »

Spirit AeroSystems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$81.74

1.4 (1.74%)

06:26
12/09/16
12/09
06:26
12/09/16
06:26
Upgrade
Autodesk rating change  »

Autodesk upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

WEGRY

Weir Group

$11.65

-0.08 (-0.68%)

06:26
12/09/16
12/09
06:26
12/09/16
06:26
Downgrade
Weir Group rating change  »

Weir Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVRR

CVR Refining

$10.40

1.25 (13.66%)

06:25
12/09/16
12/09
06:25
12/09/16
06:25
Upgrade
CVR Refining rating change  »

CVR Refining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$11.99

0.09 (0.76%)

06:25
12/09/16
12/09
06:25
12/09/16
06:25
Downgrade
Barclays rating change  »

Barclays downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

PACCAR

$68.07

0.44 (0.65%)

06:24
12/09/16
12/09
06:24
12/09/16
06:24
Upgrade
PACCAR rating change  »

PACCAR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$71.48

-0.07 (-0.10%)

06:23
12/09/16
12/09
06:23
12/09/16
06:23
Downgrade
Oshkosh rating change  »

Oshkosh downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$6.18

0.07 (1.15%)

06:22
12/09/16
12/09
06:22
12/09/16
06:22
Downgrade
Manitowoc rating change  »

Manitowoc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$34.21

0.16 (0.47%)

06:21
12/09/16
12/09
06:21
12/09/16
06:21
Downgrade
Kennametal rating change  »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$57.29

0.01 (0.02%)

06:20
12/09/16
12/09
06:20
12/09/16
06:20
Periodicals
Wells Fargo names four board members for sales scandal review, Reuters reports »

Wells Fargo named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$2.73

0.07 (2.63%)

06:20
12/09/16
12/09
06:20
12/09/16
06:20
Hot Stocks
UniCredit to sell 32.8% stake in Bank Pekao to PZN, PFR »

UniCredit announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.